New Investing App Saves Investors an Average of $97,347
Most people are terrible at buying and selling stocks at the right time, but the TradeSmith app takes the emotion out of investing.

Our back test shows, the average investor would've made $97,347 more just by using the TradeSmith app analyzer software.

Check out this FREE video.
Jennifer B. Damico, insider at Pfizer

Jennifer B. Damico Insider Information

SVP of Pfizer
Jennifer Damico is Vice President, Corporate Audit, Pfizer Inc, reporting to the Audit Committee of the Board of Directors and the Chief Financial Officer. She is responsible for leading 100 audit professionals primarily based in New York, New Jersey, Connecticut, Pennsylvania, Mumbai, Dublin and Beijing. Corporate Audit provides independent, Pan-Pfizer corporate regulatory audit and oversight of processes and systems spanning the company's operating model including: discovery, development, manufacturing, commercial sales & marketing activities, finance and information technology.

Jennifer joined Pfizer in 1992 and has held positions of increasing responsibility in Audit, Information Technology, and Finance. She joined the company as a Senior Internal Auditor and was promoted to Audit Manager in 1994. In 1997, Jennifer joined the Corporate Information Technology Division as Director of Finance and Controller. In 2001, she rejoined Internal Audit as an Audit Director and was promoted to Senior Director, Strategy, Governance and Operations in 2008. Jennifer served as the Program Management Office (PMO) Lead for the Finance One transformation program and led the finance integration for the King acquisition. In 2010, she became Vice President, Finance Portfolio Management & Optimization, and established a new organization to provide centralized, customer-focused project & change management as well as coordination of finance integration and divestiture activities which more recently included supporting the Nutritional and Animal Health divestitures. Prior to joining Pfizer, she worked as a senior auditor for Arthur Andersen.

Jennifer holds a Master of Business Administration degree from Pace University and is a Certified Public Accountant. She is married with two children Ryan, 15 and Courtney, 13 and lives in Long Island, NY.

What is Jennifer B. Damico's net worth?

The estimated net worth of Jennifer B. Damico is at least $552,495.24 as of June 7th, 2022. Ms. Damico owns 10,846 shares of Pfizer stock worth more than $552,495 as of June 30th. This net worth approximation does not reflect any other investments that Ms. Damico may own. Learn More about Jennifer B. Damico's net worth.

How old is Jennifer B. Damico?

Ms. Damico is currently 54 years old. There are 8 older executives and no younger executives at Pfizer. The oldest executive at Pfizer is Mr. Frank A. D'Amelio, CFO & Exec. VP, who is 64 years old. Learn More on Jennifer B. Damico's age.

How do I contact Jennifer B. Damico?

The corporate mailing address for Ms. Damico and other Pfizer executives is 235 EAST 42ND STREET, NEW YORK NY, 10017. Pfizer can also be reached via phone at (212) 733-2323. Learn More on Jennifer B. Damico's contact information.

Has Jennifer B. Damico been buying or selling shares of Pfizer?

During the last quarter, Jennifer B. Damico has sold $429,603.28 in shares of Pfizer stock. 0 shares of the business's stock in a transaction that occurred on Thursday, June 30th. Learn More on Jennifer B. Damico's trading history.

Who are Pfizer's active insiders?

Pfizer's insider roster includes Ronald Blaylock (Director), Loretta Cangialosi (VP), William Carapezzi, Jr. (EVP), Frank D'Amelio (EVP), Jennifer Damico (SVP), Jennifer Damico (SVP), Rady Johnson (Insider), Douglas Lankler (EVP), Alexander Mackenzie (EVP), Laurie Olson (Insider), Ian Read (CEO), Dawn Rogers (EVP), Sally Susman (Insider), and John Young (Insider). Learn More on Pfizer's active insiders.

Are insiders buying or selling shares of Pfizer?

In the last year, insiders at the biopharmaceutical company sold shares 8 times. They sold a total of 276,647 shares worth more than $14,190,373.18. The most recent insider tranaction occured on June, 7th when SVP Jennifer B Damico sold 4,218 shares worth more than $227,603.28. Insiders at Pfizer own 0.1 % of the company. Learn More about insider trades at Pfizer.

Information on this page was last updated on 6/7/2022.

Jennifer B. Damico Insider Trading History at Pfizer

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/7/2022Sell4,218$53.96$227,603.2810,846View SEC Filing Icon  
5/16/2022Sell4,000$50.50$202,000.0015,064View SEC Filing Icon  
8/13/2021Sell1,661$48.30$80,226.30View SEC Filing Icon  
7/30/2021Sell2,500$42.86$107,150.0011,430View SEC Filing Icon  
5/5/2021Sell2,500$40.82$102,050.0013,748View SEC Filing Icon  
6/5/2020Sell2,181$36.13$78,799.537,542View SEC Filing Icon  
4/29/2020Sell2,181$38.35$83,641.359,647View SEC Filing Icon  
See Full Table

Jennifer B. Damico Buying and Selling Activity at Pfizer

This chart shows Jennifer B Damico's buying and selling at Pfizer by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Pfizer Company Overview

Pfizer logo
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Read More

Today's Range

Now: $51.76
Low: $50.48
High: $52.32

50 Day Range

MA: $50.51
Low: $46.53
High: $53.99

2 Week Range

Now: $51.76
Low: $38.82
High: $61.71


529,443 shs

Average Volume

29,374,799 shs

Market Capitalization

$290.42 billion

P/E Ratio


Dividend Yield



New Investing App Saves Investors an Average of $97,347
Most people are terrible at buying and selling stocks at the right time, but the TradeSmith app takes the emotion out of investing.

Our back test shows, the average investor would've made $97,347 more just by using the TradeSmith app analyzer software.

Check out this FREE video.